US7432331B2
(en)
|
2002-12-31 |
2008-10-07 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
CA2528001A1
(fr)
*
|
2003-04-04 |
2004-10-21 |
The University Of Tokyo |
Structure de membrane lipidique comportant un anticorps monoclonal anti-mt-mmp
|
US7219017B2
(en)
|
2003-09-11 |
2007-05-15 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
US7219018B2
(en)
*
|
2003-09-11 |
2007-05-15 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
US7216038B2
(en)
|
2003-09-11 |
2007-05-08 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
US20050147664A1
(en)
*
|
2003-11-13 |
2005-07-07 |
Elan Pharma International Ltd. |
Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent delivery
|
US7393924B2
(en)
*
|
2004-01-06 |
2008-07-01 |
Franco Vitaliano |
Smart bio-nanoparticle elements
|
US8658203B2
(en)
|
2004-05-03 |
2014-02-25 |
Merrimack Pharmaceuticals, Inc. |
Liposomes useful for drug delivery to the brain
|
DK1746976T3
(en)
|
2004-05-03 |
2017-04-10 |
Merrimack Pharmaceuticals Inc |
LIPOSOMES SUITABLE FOR PHARMACEUTICAL SUPPLY
|
JPWO2006025592A1
(ja)
*
|
2004-08-31 |
2008-05-08 |
武岡 真司 |
薄膜状高分子構造体とその調製方法
|
WO2007005754A2
(fr)
*
|
2005-07-01 |
2007-01-11 |
Alza Corporation |
Vehicule d'administration de medicaments hydrophobes par liposomes
|
WO2007027159A1
(fr)
*
|
2005-08-30 |
2007-03-08 |
Agency For Science, Technology And Research |
Particule fluorescente hydrosoluble comprenant un polymère fluorescent et une molécule amphiphile enchevêtrés
|
US8101741B2
(en)
|
2005-11-02 |
2012-01-24 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
JP5072275B2
(ja)
*
|
2006-07-03 |
2012-11-14 |
テルモ株式会社 |
閉鎖小胞の分離方法、製剤の製造方法および評価方法
|
US8343539B2
(en)
*
|
2006-07-14 |
2013-01-01 |
Regents Of The University Of Minnesota |
Compounds that bind α5β1 integrin and methods of use
|
ES2553193T3
(es)
|
2006-10-27 |
2015-12-04 |
Shinji Takeoka |
Estructura polimérica similar a una película delgada y método para preparar la misma
|
CN101674853B
(zh)
|
2007-05-04 |
2013-03-27 |
玛瑞纳生物技术有限公司 |
氨基酸脂质及其用途
|
WO2008139457A2
(fr)
*
|
2007-05-10 |
2008-11-20 |
Clear Direction Ltd. |
Procédés et compositions pour le ciblage de médicaments
|
US20090047318A1
(en)
*
|
2007-08-16 |
2009-02-19 |
Abbott Cardiovascular Systems Inc. |
Nanoparticle-coated medical devices and formulations for treating vascular disease
|
US9789194B2
(en)
|
2007-11-27 |
2017-10-17 |
Rutgers, The State University Of New Jersey |
Graft copolymer polyelectrolyte complexes for drug delivery
|
US9271933B2
(en)
*
|
2007-11-27 |
2016-03-01 |
Rutgers, The State University Of New Jersey |
Graft copolymer polyelectrolyte complexes for drug delivery
|
EP2229583B1
(fr)
|
2007-12-06 |
2019-04-10 |
Genalyte Inc. |
Système et procédé de surveillance de synthèse d'acide nucléique sans marqueurs
|
WO2009120247A2
(fr)
*
|
2007-12-27 |
2009-10-01 |
The Ohio State University Research Foundation |
Compositions de nanoparticules de lipides et procédés de préparation et d’utilisation de celles-ci
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
KR101004709B1
(ko)
|
2007-12-28 |
2011-01-04 |
강원대학교산학협력단 |
글루코스 산화효소가 고정화된 베시클의 제조방법
|
US20110105995A1
(en)
*
|
2008-01-16 |
2011-05-05 |
Zhu Ting F |
Uniform-sized, multi-drug carrying, and photosensitive liposomes for advanced drug delivery
|
AU2009236219B8
(en)
|
2008-04-15 |
2015-06-25 |
Arbutus Biopharma Corporation |
Silencing of CSN5 gene expression using interfering RNA
|
JP2012505913A
(ja)
|
2008-10-16 |
2012-03-08 |
マリーナ バイオテック,インコーポレイテッド |
遺伝子発現を抑制する治療におけるリポソームによる効率的な送達のプロセスおよび組成物
|
US9846126B2
(en)
|
2008-10-27 |
2017-12-19 |
Genalyte, Inc. |
Biosensors based on optical probing and sensing
|
US11235062B2
(en)
*
|
2009-03-06 |
2022-02-01 |
Metaqor Llc |
Dynamic bio-nanoparticle elements
|
US11096901B2
(en)
|
2009-03-06 |
2021-08-24 |
Metaqor Llc |
Dynamic bio-nanoparticle platforms
|
JP5851399B2
(ja)
*
|
2009-07-09 |
2016-02-03 |
マリーナ バイオテック,インコーポレイテッド |
イミノ脂質を含む両性リポソーム
|
JP5646620B2
(ja)
*
|
2009-07-17 |
2014-12-24 |
インダストリー アカデミック コーポレーション ファウンデーション, ハルリム ユニバーシティー |
リポソームに被包されたオリゴヌクレオチド及びエピトープを含む免疫増強用組成物
|
WO2011120023A1
(fr)
|
2010-03-26 |
2011-09-29 |
Marina Biotech, Inc. |
Composés d'acide nucléique pour inhiber l'expression de gène de survivine et utilisations de ceux-ci
|
US20110237686A1
(en)
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc |
Formulations and methods of use
|
WO2011133584A2
(fr)
|
2010-04-19 |
2011-10-27 |
Marina Biotech, Inc. |
Composés de type acide nucléique pour inhiber l'expression du gène hras et leurs utilisations
|
WO2011139842A2
(fr)
|
2010-04-28 |
2011-11-10 |
Marina Biotech, Inc. |
Composés d'acide nucléique destinés à inhiber l'expression du gène fgfr3 et utilisations associées
|
US20130164380A1
(en)
|
2010-06-17 |
2013-06-27 |
Actogenix Nv |
Compositions and methods for treating inflammatory conditions
|
CA2816995C
(fr)
|
2010-11-05 |
2019-12-31 |
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, a body corporate and politic |
Systemes optiques de detection d'analytes et leurs procedes d'utilisation
|
EP2670843B1
(fr)
|
2011-02-03 |
2014-10-29 |
The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services |
Vaccins multivalents contre le virus de la rage et les filovirus
|
WO2013014073A1
(fr)
*
|
2011-07-22 |
2013-01-31 |
Universite De Strasbourg |
Conjugués de phospholipide-détergent et leurs utilisations
|
US8883989B2
(en)
|
2011-10-18 |
2014-11-11 |
Regents Of The University Of Minnesota |
Fractalkine binding polynucleotides and methods of use
|
CA2856116A1
(fr)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Compositions de commutateurs arn therapeutiques et procedes d'utilisation
|
WO2013086373A1
(fr)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Lipides pour l'administration d'agents actifs
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
BR112014021068A8
(pt)
|
2012-02-21 |
2018-01-23 |
Centre National De La Recherce Scient |
inibidor de uma interação entre fosfatidilserina e um receptor tim, composição farmacêutica e uso de um inibidor
|
EP2817328A1
(fr)
|
2012-02-21 |
2014-12-31 |
Institut National de la Santé et de la Recherche Médicale |
Récepteurs tam comme cofacteurs d'entrée de virus
|
US20130261010A1
(en)
|
2012-03-12 |
2013-10-03 |
The Board Of Trustees Of The University Of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of use
|
US9717724B2
(en)
|
2012-06-13 |
2017-08-01 |
Ipsen Biopharm Ltd. |
Methods for treating pancreatic cancer using combination therapies
|
AU2013202947B2
(en)
|
2012-06-13 |
2016-06-02 |
Ipsen Biopharm Ltd. |
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
|
AU2013295242C1
(en)
|
2012-07-27 |
2018-08-09 |
Institut National De La Sante Et De La Recherche Medicale |
CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
PL2897620T3
(pl)
|
2012-09-21 |
2020-11-02 |
Intensity Therapeutics, Inc |
Sposób leczenia nowotworu złośliwego
|
ES2904276T3
(es)
|
2013-09-27 |
2022-04-04 |
Massachusetts Inst Technology |
Nanoestructuras de proteínas biológicamente activas sin vehículo
|
CN105829886B
(zh)
|
2013-12-20 |
2018-04-03 |
豪夫迈·罗氏有限公司 |
使用包含聚乙二醇部分的化合物在支持物上固定细胞的方法
|
JP6629736B2
(ja)
|
2013-12-20 |
2020-01-15 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
1以上の疎水性ドメインおよびpeg部分を含む親水性ドメインを含む、細胞を結合するのに有用な化合物
|
JP6461973B2
(ja)
*
|
2013-12-20 |
2019-01-30 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
2以上の疎水性ドメインおよびpeg部分を含む親水性ドメインを含む化合物の、細胞の安定化のための使用
|
US9457041B2
(en)
|
2014-06-20 |
2016-10-04 |
Ndsu Research Foundation |
Controlled release nanoparticles and methods of use
|
EP3201338B1
(fr)
|
2014-10-02 |
2021-11-03 |
Arbutus Biopharma Corporation |
Compositions et méthodes d'extinction de l'expression du gène du virus de l'hépatite b
|
US11318131B2
(en)
|
2015-05-18 |
2022-05-03 |
Ipsen Biopharm Ltd. |
Nanoliposomal irinotecan for use in treating small cell lung cancer
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
US20180208932A1
(en)
|
2015-07-29 |
2018-07-26 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
EP3334417A4
(fr)
|
2015-08-12 |
2019-07-17 |
Massachusetts Institute of Technology |
Couplage de nanoparticules à la surface cellulaire
|
PT3337467T
(pt)
|
2015-08-20 |
2021-01-25 |
Ipsen Biopharm Ltd |
Terapia de combinação utilizando irinotecano lipossomal e um inibidor parp para tratamento do cancro
|
WO2017034957A1
(fr)
|
2015-08-21 |
2017-03-02 |
Merrimack Pharmaceuticals, Inc. |
Méthodes permettant de traiter le cancer du pancréas métastatique au moyen de traitements d'association comprenant de l'irinotécan liposomal et de l'oxaliplatine
|
AU2016340153B2
(en)
|
2015-10-16 |
2022-06-02 |
Ipsen Biopharm Ltd. |
Stabilizing camptothecin pharmaceutical compositions
|
US11696959B2
(en)
*
|
2015-12-31 |
2023-07-11 |
City Of Hope |
Nanoparticle-cell construct with platinum anti-cancer agent
|
AU2017224113B2
(en)
|
2016-02-25 |
2022-04-21 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
US20170360815A1
(en)
|
2016-02-25 |
2017-12-21 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
EP4104854A3
(fr)
|
2016-04-04 |
2023-03-08 |
The United States of America as represented by the Secretary of the Department of Health and Human Services |
Vaccins multivalents pour le virus de la rage et les coronavirus
|
AU2017283480A1
(en)
|
2016-06-13 |
2019-01-24 |
Torque Therapeutics, Inc. |
Methods and compositions for promoting immune cell function
|
CN106309370A
(zh)
*
|
2016-09-20 |
2017-01-11 |
上海上药新亚药业有限公司 |
一种紫杉醇pH敏长循环脂质体及其制备方法
|
WO2018083470A1
(fr)
|
2016-11-02 |
2018-05-11 |
Ipsen Biopharm Ltd. |
Traitement du cancer gastrique au moyen de polythérapies comprenant de l'oxaliplatine, du 5-fluoruracile (et de la leucovorine) et de l'irinotécan sous forme liposomale
|
US20170172921A1
(en)
*
|
2016-12-14 |
2017-06-22 |
Mahmoud Reza Jaafari |
Polyphenolic compounds encapsualated in long circulating liposomes and use thereof
|
US11433143B2
(en)
*
|
2017-05-18 |
2022-09-06 |
The Regents Of The University Of California |
Nano-enabled immunotherapy in cancer
|
EP3678701A4
(fr)
|
2017-09-05 |
2021-12-01 |
Torque Therapeutics, Inc. |
Compositions protéiques thérapeutiques et procédés de préparation et d'utilisation de celles-ci
|
EP3713603A1
(fr)
|
2017-11-23 |
2020-09-30 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Nouveau procédé de traitement d'une infection par le virus de la dengue
|
CA3134828A1
(fr)
*
|
2019-03-29 |
2020-10-08 |
Glycomine, Inc. |
Formulations liposomales et leurs procedes d'utilisation et de preparation
|
WO2021108195A1
(fr)
|
2019-11-26 |
2021-06-03 |
Board Of Regents, The University Of Texas System |
Traitement par bdellovibrio pour la sclérose latérale amyotrophique
|
CN111481507B
(zh)
*
|
2020-04-10 |
2021-10-29 |
浙江大学 |
一种酶促阳离子化脂质体及其应用
|